Tobacco Center Faculty Blog

November 5, 2013

Stanton A. Glantz, PhD

Under the 2009 Family Smoking and Prevention Tobacco Control Act (FSPTCA) there are two ways in which the FDA can approve a new tobacco product to be marketed: (1) a tobacco company can submit a “new product” application, or (2) it can submit a “substantial equivalence” application to the FDA making the case that the new product is “substantially equivalent” to a product already on the market as of February 15, 2007.

To date there have been over 4,300 substantial equivalence applications (and no new product applications), so the scientific standards that the FDA uses to determine that a new product is “substantially equivalent” are very important in terms of determining the public health impact of approving the new product.  It is, therefore, particularly important that the public know precisely on what grounds such decisions are being made.

November 3, 2013

Stanton A. Glantz, PhD

Check it out at http://billmoyers.com/segment/yves-smith-and-dean-baker-on-secrets-in-trade/.  The discussion is an excellent introduction to all the arcane issues around the Trans Pacific Partnership.
 
The last sentence in the discussion says it all:  "There would be no reason to keep it so secret if it was in the interest of the public.”

October 21, 2013

Stanton A. Glantz, PhD

Stan Glantz talking about ecigs on NPR All Things Considered  on October 21, 2013.  Listen to it here.

October 19, 2013

Stanton A. Glantz, PhD

No spooky chemicals or other  foreign ingredients in e-cigs.
Just pure nicotine.
For beginners, it's the perfect starter kit in candy counter flavors.
No burning, choking hard-to-get-used-to smoke.
For  longtime cigarette smokers guaranteed  nicotine dependency.
e-cigs. Pure Addiction.

 
(Paul Keye developed the original California anti-tobacco ad campaign.)
 
Of course, ecigs are not just pure nicotine.  But a little artistic license is ok (since Paul is not selling them).

October 16, 2013

Stanton A. Glantz, PhD

As Martin McKee wrote in the BMJ on October 16, the revisions just made to the draft EU Tobacco Products directive were a big win for the tobacco companies who are pushing e-cigarettes:

Pages